BindingDB PrimarySearch

Found 50 Enz. Inhib. hit(s) with Target = 'Xanthine dehydrogenase/oxidase' and Ligand = 'BDBM50140241'

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

Ki: 100nMAssay Description:Inhibition of human xanthine oxidaseMore data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2QJ7M9SPubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

Ki: 700nMMore data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q27085HMPubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

Ki: 700nMAssay Description:Inhibition of xanthine oxidase (unknown origin)More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q20C50BSPubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 3.60nMAssay Description:Inhibition of xanthine oxidase (unknown origin) assessed as reduction in uric acid formation preincubated for 5 mins followed by addition of xanthine...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2W37Z90PubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 100nMAssay Description:Inhibition of xanthine oxidase (unknown origin) assessed as reduction in uric acid formation using xanthine as substrate after 10 minsMore data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2VD71XPPubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2VD71XPPubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 200nMAssay Description:Inhibition of xanthine oxidase (unknown origin)More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q23F4RJTPubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 250nMAssay Description:Inhibition of bovine milk xanthine oxidase using xanthine as substrate preincubated for 15 mins followed by substrate addition measured after 30 mins...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2X35144PubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 260nMAssay Description:Inhibition of bovine milk xanthine-oxygen reductase using xanthine as substrate by spectrophotometric assayMore data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2VD71XPPubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 600nMMore data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q25Q512MPubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 950nMAssay Description:Inhibition of xanthine oxidase (unknown origin) using xanthine as substrate assessed as inhibition of uric acid formation after 30 mins by spectropho...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2W37Z8JPubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 1.00E+3nMAssay Description:Inhibition of bovine milk xanthine oxidase assessed as reduction in uric acid production using xanthine as substrate after 10 mins by HPLC analysisMore data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2DF6VJMPubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 1.00E+3nMAssay Description:Inhibition of xanthine oxidase (unknown origin) using xanthine as substrate pretreated for 10 mins followed by substrate addition measured every 2 mi...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2P55R10PubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 2.00E+3nMAssay Description:Inhibition of xanthine oxidase (unknown origin) using xanthine as substrate measured at every 1 mins up to 5 minsMore data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2VD71XPPubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 2.00E+3nMAssay Description:Xanthine oxidase inhibition was determined using a standard fluorescence-based assay for xanthine oxidase activity (McHale A, Grimes H, Coughlan MP: ...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details
BindingDB Entry DOI: 10.7270/Q2BG2S52US Patent

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 2.00E+3nMAssay Description:Inhibition of bovine xanthine oxidase using xanthine as substrate preincubated for 10 mins followed by substrate addition measured for 15 mins by spe...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2C82CKQPubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 2.20E+3nMAssay Description:Inhibition of xanthine oxidase (unknown origin)More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2NS0ZFVPubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 2.52E+3nMAssay Description:Inhibition of bovine milk xanthine oxidase assessed as reduction in uric acid formation using xanthine as substrate measured for 20 mins by microplat...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2K93C5XPubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 2.60E+3nMAssay Description:Inhibition of bovine milk xanthine oxidase using xanthine as substrate pretreated for 15 mins followed by substrate addition measured after 8 minsMore data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2BZ68M1PubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 2.90E+3nMAssay Description:Inhibition of Xanthine oxidase (unknown origin) using xanthine as substrate preincubated for 1 to 5 mins followed by substrate additionMore data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2QZ2DK4PubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 3.17E+3nMAssay Description:Inhibition of xanthine oxidase (unknown origin) at 30 uM using xanthine as substrate preincubated for 5 mins followed by substrate addition measured ...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2V40XQBPubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 3.50E+3nMAssay Description:Xanthine oxidase inhibition was determined using a standard fluorescence-based assay for xanthine oxidase activity (McHale A, Grimes H, Coughlan M P:...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details
BindingDB Entry DOI: 10.7270/Q26M3B0ZUS Patent

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 3.53E+3nMAssay Description:Inhibition of bovine milk xanthine oxidase assessed as reduction in uric acid formation using xanthine as substrate preincubated for 3 hrs followed b...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2VD71XPPubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2VD71XPPubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 3.61E+3nMAssay Description:Inhibition of Xanthine oxidase (unknown origin) using xanthine as substrate preincubated for 3 mins followed by substrate addition measured every 15 ...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2SJ1NVQPubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 3.89E+3nMAssay Description:Inhibition of xanthine oxidase- mediated uric acid formation after 5 mins by spectrophotometryMore data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2S46VVZPubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 4.20E+3nMAssay Description:Inhibition of cow milk xanthine oxidoreductase using hypoxanthine by spectrophotometryMore data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2474DFKPubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 5.46E+3nMAssay Description:Inhibition of bovine milk xanthine oxidase assessed as reduction in uric acid formation using xanthine as substrate preincubated for 15 mins followed...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q261144NPubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 6.43E+3nMAssay Description:Inhibition of bovine xanthine oxidase assessed as reduction in uric acid formation preincubated for 5 mins followed by xanthine addition and measured...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2DF6VNZPubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 7.56E+3nMAssay Description:Inhibition of bovine xanthine oxidase assessed as reduction in uric acid production using xanthine as substrate preincubated for 10 mins followed by ...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2QC060DPubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 7.59E+3nMMore data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q27085HMPubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 7.59E+3nMAssay Description:Inhibition of bovine xanthine oxidase assessed as reduction in uric acid formation using xanthine as substrate preincubated for 25 mins followed by s...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2280CCGPubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 7.59E+3nMAssay Description:Inhibition of bovine milk xanthine oxidase using xanthine as substrate incubated for 15 mins followed by substrate addition and measured at 30 sec in...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q21N84KSPubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 7.59E+3nMAssay Description:Inhibition of bovine xanthine oxidase assessed as reduction in uric acid formation using xanthine as substrate preincubated with enzyme for 15 mins f...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2ST7T69PubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 8.31E+3nMAssay Description:Inhibition of bovine milk xanthine oxidase assessed as reduction in uric acid formation using xanthine as substrate preincubated for 5 mins followed ...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2VD71XPPubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 8.37E+3nMMore data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2Z03D63PubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 8.50E+3nMAssay Description:Antagonistic activity against the P2X7 ion channelMore data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2FJ2K90PubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 9.80E+3nMMore data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2T43Z4ZPubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 9.80E+3nMAssay Description:Inhibition of bovine xanthine oxidase assessed as reduction in uric acid levels using xanthine as substrate after 120 mins by spectrophotometryMore data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2GX4DS2PubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 1.06E+4nMAssay Description:Inhibition of bovine xanthine oxidase using xanthine as substrate preincubated for 3 mins followed by substrate addition and measured for every 15 se...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2VT1VT4PubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 1.17E+4nMAssay Description:Inhibition of xanthine oxidase (unknown origin) using xanthine as substrate assessed as uric acid formation preincubated for 5 mins followed by subst...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2G44T7XPubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 1.25E+4nMMore data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q21V5JZMPubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 1.96E+4nMAssay Description:Inhibition of bovine milk xanthine oxidase pre-incubated for 30 mins followed by xanthine addition and measured every 30 secs for 5 mins by spectroph...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2F76G1KPubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 2.43E+4nMAssay Description:Inhibition of xanthine oxidase (unknown origin) by SAR analysisMore data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2VD71XPPubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 3.07E+4nMAssay Description:Inhibition of xanthine oxidase (unknown origin) assessed as reduction in uric acid formation using xanthine as substrate after 4 mins by UV-Vis spect...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2VD71XPPubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 3.16E+4nMAssay Description:Inhibition of xanthine oxidase (unknown origin)More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q28W3H1VPubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 4.40E+4nMAssay Description:Inhibition of bovine milk xanthine oxidase using xanthine as substrate preincubated for 15 mins followed by substrate addition by spectrophotometric ...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2K64KZ2PubMed

Xanthine dehydrogenase/oxidase(Homo sapiens (Human))
University of California

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 5.02E+4nMAssay Description:Inhibition of xanthine oxidase (unknown origin) using xanthine as substrate preincubated for 15 mins followed by substrate addition by spectrophotome...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD DrugBank antibodypedia GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q24Q7XD9PubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

IC50: 2.58E+5nMAssay Description:Inhibition of bovine milk xanthine oxidase assessed using xanthine as substrate after 10 mins by fluorometric assayMore data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2VD71XPPubMed

Xanthine dehydrogenase/oxidase(Bos taurus (Bovine))
Universidad Nacional de C£rdoba

Curated by ChEMBL

BDBM50140241(Allopurinol | Aloral | Aluline 100 | Aluline 300 |...)copy SMILEScopy InChI

Kd: 0.540nMAssay Description:Binding affinity to bovine milk xanthine oxidase assessed as reduction in conversion of 4-HPP to 4,6-diHPP by measuring cytochrome c reduction by spe...More data for this Ligand-Target Pair

PDB MMDB KEGG
UniProtKB/SwissProt
B.MOAD GoogleScholar

Purchase MCE
PC cid PC sid Similars

Details Article
BindingDB Entry DOI: 10.7270/Q2VD71XPPubMed

Targets 1 ▿
- Xanthine dehydrogenase/oxidase 50
Publications 29 ▿
- Eur J Med Chem 135: 491-516 (2017) 11
- Bioorg Med Chem Lett 30: (2020) 1
- Eur J Med Chem 143: 577-582 (2018) 1
- Bioorg Med Chem 24: 578-87 (2016) 1
- Eur J Med Chem 181: (2019) 1
- Eur J Med Chem 119: 197-217 (2016) 1
- Eur J Med Chem 140: 20-30 (2017) 1
- Eur J Med Chem 67: 152-7 (2013) 1
- Bioorg Med Chem Lett 27: 3602-3606 (2017) 1
- J Nat Prod 77: 1693-9 (2014) 1
- Eur J Med Chem 143: 829-842 (2018) 1
- Eur J Med Chem 166: 186-196 (2019) 1
- Bioorg Med Chem Lett 27: 729-732 (2017) 1
- Eur J Med Chem 181: (2019) 1
- Bioorg Med Chem 27: 1818-1823 (2019) 1
- J Nat Prod 82: 205-210 (2019) 1
- Eur J Med Chem 141: 362-372 (2017) 1
- Bioorg Med Chem Lett 22: 4625-8 (2012) 1
- J Nat Prod 80: 2778-2786 (2017) 1
- Eur J Med Chem 156: 394-429 (2018) 1
- Bioorg Med Chem 25: 3562-3566 (2017) 1
- Bioorg Med Chem 25: 2351-2371 (2017) 1
- Bioorg Med Chem 26: 1653-1664 (2018) 1
- Eur J Med Chem 124: 637-648 (2016) 1
- Eur J Med Chem 151: 849-860 (2018) 1
- Bioorg Med Chem Lett 26: 2874-2879 (2016) 1
- Bioorg Med Chem 25: 166-174 (2017) 1
- Bioorg Med Chem 26: 536-542 (2018) 1
- Bioorg Med Chem Lett 27: 3812-3816 (2017) 1
Institutions 23 ▿
- [Department of Chemistry, Faculty of Medicine, University of Ni?, Bulevar Dr Zorana?in?i?a 81, 18000 Ni?, Serbia.] 11
- [Shenyang Pharmaceutical University, Soochow University] 3
- [Shenyang Pharmaceutical University, Soochow University] 3
- [China Pharmaceutical University, China Medical University] 2
- [China Pharmaceutical University, China Medical University] 2
- [West China Hospital of Sichuan University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical Universi, South China University of Technology, Aix Marseille Universit£, Sichuan University, University of California, National Institute of Medicinal Materials, Universidad Nacional de C£rdoba, Seoul National University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), School of Pharmacy, China Medical University, 77 Puhe Road, North New Area, Shenyang 110122, China., University of Shizuoka, Tohoku Medical and Pharmaceutical University, University of Beira Interior, Northern Kentucky University, University of Aveiro, University of Karachi, Guangxi Medical University] 1
- [West China Hospital of Sichuan University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical Universi, South China University of Technology, Aix Marseille Universit£, Sichuan University, University of California, National Institute of Medicinal Materials, Universidad Nacional de C£rdoba, Seoul National University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), School of Pharmacy, China Medical University, 77 Puhe Road, North New Area, Shenyang 110122, China., University of Shizuoka, Tohoku Medical and Pharmaceutical University, University of Beira Interior, Northern Kentucky University, University of Aveiro, University of Karachi, Guangxi Medical University] 1
- [West China Hospital of Sichuan University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical Universi, South China University of Technology, Aix Marseille Universit£, Sichuan University, University of California, National Institute of Medicinal Materials, Universidad Nacional de C£rdoba, Seoul National University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), School of Pharmacy, China Medical University, 77 Puhe Road, North New Area, Shenyang 110122, China., University of Shizuoka, Tohoku Medical and Pharmaceutical University, University of Beira Interior, Northern Kentucky University, University of Aveiro, University of Karachi, Guangxi Medical University] 1
- [West China Hospital of Sichuan University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical Universi, South China University of Technology, Aix Marseille Universit£, Sichuan University, University of California, National Institute of Medicinal Materials, Universidad Nacional de C£rdoba, Seoul National University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), School of Pharmacy, China Medical University, 77 Puhe Road, North New Area, Shenyang 110122, China., University of Shizuoka, Tohoku Medical and Pharmaceutical University, University of Beira Interior, Northern Kentucky University, University of Aveiro, University of Karachi, Guangxi Medical University] 1
- [West China Hospital of Sichuan University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical Universi, South China University of Technology, Aix Marseille Universit£, Sichuan University, University of California, National Institute of Medicinal Materials, Universidad Nacional de C£rdoba, Seoul National University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), School of Pharmacy, China Medical University, 77 Puhe Road, North New Area, Shenyang 110122, China., University of Shizuoka, Tohoku Medical and Pharmaceutical University, University of Beira Interior, Northern Kentucky University, University of Aveiro, University of Karachi, Guangxi Medical University] 1
- [West China Hospital of Sichuan University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical Universi, South China University of Technology, Aix Marseille Universit£, Sichuan University, University of California, National Institute of Medicinal Materials, Universidad Nacional de C£rdoba, Seoul National University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), School of Pharmacy, China Medical University, 77 Puhe Road, North New Area, Shenyang 110122, China., University of Shizuoka, Tohoku Medical and Pharmaceutical University, University of Beira Interior, Northern Kentucky University, University of Aveiro, University of Karachi, Guangxi Medical University] 1
- [West China Hospital of Sichuan University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical Universi, South China University of Technology, Aix Marseille Universit£, Sichuan University, University of California, National Institute of Medicinal Materials, Universidad Nacional de C£rdoba, Seoul National University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), School of Pharmacy, China Medical University, 77 Puhe Road, North New Area, Shenyang 110122, China., University of Shizuoka, Tohoku Medical and Pharmaceutical University, University of Beira Interior, Northern Kentucky University, University of Aveiro, University of Karachi, Guangxi Medical University] 1
- [West China Hospital of Sichuan University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical Universi, South China University of Technology, Aix Marseille Universit£, Sichuan University, University of California, National Institute of Medicinal Materials, Universidad Nacional de C£rdoba, Seoul National University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), School of Pharmacy, China Medical University, 77 Puhe Road, North New Area, Shenyang 110122, China., University of Shizuoka, Tohoku Medical and Pharmaceutical University, University of Beira Interior, Northern Kentucky University, University of Aveiro, University of Karachi, Guangxi Medical University] 1
- [West China Hospital of Sichuan University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical Universi, South China University of Technology, Aix Marseille Universit£, Sichuan University, University of California, National Institute of Medicinal Materials, Universidad Nacional de C£rdoba, Seoul National University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), School of Pharmacy, China Medical University, 77 Puhe Road, North New Area, Shenyang 110122, China., University of Shizuoka, Tohoku Medical and Pharmaceutical University, University of Beira Interior, Northern Kentucky University, University of Aveiro, University of Karachi, Guangxi Medical University] 1
- [West China Hospital of Sichuan University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical Universi, South China University of Technology, Aix Marseille Universit£, Sichuan University, University of California, National Institute of Medicinal Materials, Universidad Nacional de C£rdoba, Seoul National University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), School of Pharmacy, China Medical University, 77 Puhe Road, North New Area, Shenyang 110122, China., University of Shizuoka, Tohoku Medical and Pharmaceutical University, University of Beira Interior, Northern Kentucky University, University of Aveiro, University of Karachi, Guangxi Medical University] 1
- [West China Hospital of Sichuan University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical Universi, South China University of Technology, Aix Marseille Universit£, Sichuan University, University of California, National Institute of Medicinal Materials, Universidad Nacional de C£rdoba, Seoul National University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), School of Pharmacy, China Medical University, 77 Puhe Road, North New Area, Shenyang 110122, China., University of Shizuoka, Tohoku Medical and Pharmaceutical University, University of Beira Interior, Northern Kentucky University, University of Aveiro, University of Karachi, Guangxi Medical University] 1
- [West China Hospital of Sichuan University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical Universi, South China University of Technology, Aix Marseille Universit£, Sichuan University, University of California, National Institute of Medicinal Materials, Universidad Nacional de C£rdoba, Seoul National University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), School of Pharmacy, China Medical University, 77 Puhe Road, North New Area, Shenyang 110122, China., University of Shizuoka, Tohoku Medical and Pharmaceutical University, University of Beira Interior, Northern Kentucky University, University of Aveiro, University of Karachi, Guangxi Medical University] 1
- [West China Hospital of Sichuan University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical Universi, South China University of Technology, Aix Marseille Universit£, Sichuan University, University of California, National Institute of Medicinal Materials, Universidad Nacional de C£rdoba, Seoul National University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), School of Pharmacy, China Medical University, 77 Puhe Road, North New Area, Shenyang 110122, China., University of Shizuoka, Tohoku Medical and Pharmaceutical University, University of Beira Interior, Northern Kentucky University, University of Aveiro, University of Karachi, Guangxi Medical University] 1
- [West China Hospital of Sichuan University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical Universi, South China University of Technology, Aix Marseille Universit£, Sichuan University, University of California, National Institute of Medicinal Materials, Universidad Nacional de C£rdoba, Seoul National University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), School of Pharmacy, China Medical University, 77 Puhe Road, North New Area, Shenyang 110122, China., University of Shizuoka, Tohoku Medical and Pharmaceutical University, University of Beira Interior, Northern Kentucky University, University of Aveiro, University of Karachi, Guangxi Medical University] 1
- [West China Hospital of Sichuan University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical Universi, South China University of Technology, Aix Marseille Universit£, Sichuan University, University of California, National Institute of Medicinal Materials, Universidad Nacional de C£rdoba, Seoul National University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), School of Pharmacy, China Medical University, 77 Puhe Road, North New Area, Shenyang 110122, China., University of Shizuoka, Tohoku Medical and Pharmaceutical University, University of Beira Interior, Northern Kentucky University, University of Aveiro, University of Karachi, Guangxi Medical University] 1
- [West China Hospital of Sichuan University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical Universi, South China University of Technology, Aix Marseille Universit£, Sichuan University, University of California, National Institute of Medicinal Materials, Universidad Nacional de C£rdoba, Seoul National University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), School of Pharmacy, China Medical University, 77 Puhe Road, North New Area, Shenyang 110122, China., University of Shizuoka, Tohoku Medical and Pharmaceutical University, University of Beira Interior, Northern Kentucky University, University of Aveiro, University of Karachi, Guangxi Medical University] 1
- [West China Hospital of Sichuan University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical Universi, South China University of Technology, Aix Marseille Universit£, Sichuan University, University of California, National Institute of Medicinal Materials, Universidad Nacional de C£rdoba, Seoul National University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), School of Pharmacy, China Medical University, 77 Puhe Road, North New Area, Shenyang 110122, China., University of Shizuoka, Tohoku Medical and Pharmaceutical University, University of Beira Interior, Northern Kentucky University, University of Aveiro, University of Karachi, Guangxi Medical University] 1
- [West China Hospital of Sichuan University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), Ministry of Education, School of Traditional Chinese Materia Medica, Shenyang Pharmaceutical Universi, South China University of Technology, Aix Marseille Universit£, Sichuan University, University of California, National Institute of Medicinal Materials, Universidad Nacional de C£rdoba, Seoul National University, Key Laboratory of Structure-Based Drug Design and Discovery (Shenyang Pharmaceutical University), School of Pharmacy, China Medical University, 77 Puhe Road, North New Area, Shenyang 110122, China., University of Shizuoka, Tohoku Medical and Pharmaceutical University, University of Beira Interior, Northern Kentucky University, University of Aveiro, University of Karachi, Guangxi Medical University] 1
Affinity: 0.54 to 2.6E+5 nM▿
- Ki 3
- IC50 46
- Kd 1
- Affinity ≤ nM
Xtal structures: 0
Docked structures: 0
Catalog Cmpds: 1